Risk factor
Considerable default risk
Profitability factor
Favourable price performance
About
i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan,...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITD.
Target Price
The average target price of 099190.KQ is 25850 and suggests 15% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommend
Buy
Sell